Bravida Medical, headquartered in the United States, is a prominent player in the medical technology industry, specialising in innovative healthcare solutions. Founded in [year], the company has established a strong presence across major operational regions, focusing on enhancing patient care through advanced medical devices and services. With a commitment to quality and innovation, Bravida Medical offers a range of core products, including [specific products/services], which are distinguished by their cutting-edge technology and user-friendly design. The company has achieved notable milestones, positioning itself as a trusted partner in the healthcare sector, recognised for its contributions to improving clinical outcomes. Bravida Medical's dedication to excellence has earned it a significant market position, making it a preferred choice among healthcare professionals seeking reliable and effective medical solutions.
How does Bravida Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bravida Medical's score of 42 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Bravida Medical reported total carbon emissions of approximately 427,658,000 kg CO2e, with emissions distributed across all three scopes: 1, 2, and 3. Specifically, Scope 1 emissions were about 1,587,000 kg CO2e, while Scope 2 emissions totalled approximately 51,366,000 kg CO2e. The majority of emissions stemmed from Scope 3, which accounted for about 427,658,000 kg CO2e. In 2023, the company recorded slightly lower emissions, with Scope 1 at about 1,585,000 kg CO2e, Scope 2 at approximately 40,039,000 kg CO2e, and Scope 3 at around 327,241,000 kg CO2e. Bravida Medical has not set specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. The company operates independently without cascading emissions data from a parent organisation. As such, their climate commitments remain unspecified, highlighting a potential area for future development in sustainability practices.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 2,471,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 47,066,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 374,263,000 | 000,000,000 | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bravida Medical has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
